StockGlow

BioNTech SE (22UA.DE)

Develops mRNA vaccines and cancer treatments to train the immune system to fight disease.

80.70+0.00%Healthcare
Compare 22UA.DE with
StockGlow Score
41
Neutral
BearishBullish
1 year ago-12.3%

The outlook

BioNTech is trading near the lower third of its 52-week range at €80.70. The stock sits mixed relative to its moving averages, suggesting no clear directional momentum. Analyst coverage leans neutral overall, with sentiment neither notably bullish nor bearish at present.

What’s behind the score

Price trendMixed vs its moving averages
52-week range33% of the way from its 52-week low to high
Market cap
$20.41B
52-wk high
105.70
52-wk low
68.30
50-day avg
79.51
200-day avg
84.32
Trailing P/E
—

Similar stocks

PFE.DEPfizer Inc.$22.16+0.05%22UA.FBioNTech SE$80.50+0.69%0QF.DEModerna, Inc.$49.09+2.46%MSF.DEMicrosoft Corporation$346.45-1.17%0QF.FModerna, Inc.$48.45+1.60%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy